Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vivos Inc (OP: RDGL )

0.0989 -0.0042 (-4.07%)
Streaming Delayed Price Updated: 2:02 PM EDT, Apr 19, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 924,335
Open 0.1031
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.1031
Today's Range 0.0975 - 0.1031
52wk Range 0.0412 - 0.1199
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Stocks to Turn $1,000 Into $1 Million: February 2024
Although these millionaire-maker stocks are incredibly risky, the rewards if the circumstances align just right could be phenomenal. 
Via InvestorPlace
High-Risk, High-Reward: 7 OTC Stocks That Could Make You Rich This Year
Although OTC stocks can be wildly risky, these ideas could offer speculators opportunities that the rest of the market doesn’t see. 
Via InvestorPlace

Performance

YTD
+30.13%
+30.13%
1 Month
+45.01%
+45.01%
3 Month
+52.15%
+52.15%
6 Month
+81.14%
+81.14%
1 Year
+41.89%
+41.89%

More News

Read More
New Hope In Cancer Battle: FDA Grants Breakthrough Device Status To Vivos Inc.'s RadioGel
Via Benzinga
Exposures Product Safety
Radiogel Precision Radionuclide Therapy Receives FDA Breakthrough Device Designation
Via NewMediaWire
Exposures Product Safety
Gossamer Bio And 2 Other Stocks Under $1 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
Black Diamond Therapeutics And 2 Other Stocks Under $3 Insiders Are Buying
Via Benzinga
Topics Stocks
Exposures US Equities
Great Elm Group And 3 Other Stocks Under $5 Insiders Are Aggressively Buying
Via Benzinga
Insiders Buying These 4 Penny Stocks
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.